Thousands of people are evacuated from their homes in central and southern Philippines as Typhoon Rai, described as one of the strongest storms of the year, begins to make landfall in mid-eastern parts of the country, with warnings of very destructive typhoon-force winds. (Al Jazeera)
The Malaysiangovernment announces that due to the threat of the Omicron variant, there will be a ban on all large-scale Christmas and New Year's Eve celebrations. The government will also require people over the age of 60 as well as adults who received the SinovacCoronavac vaccine to receive a booster dose before February in order to maintain their full vaccination status. (Malay Mail)
The Palestinian Authority reports its first cases of the Omicron variant in three people from different cities in the West Bank who travelled abroad. (AP)
The Danish Health Authority approves the usage of the Molnupiravir antiviral pill developed by Merck & Co. for at-risk patients with symptoms, becoming the first EU country to authorize the usage of this drug. (NDTV)
Denmark reports a record 9,999 new cases of COVID-19 in the past 24 hours. (CPH Post)
Italy imposes mandatory COVID-19 testing for all travellers from European Union countries and mandates a five-day quarantine on arrival for those who are unvaccinated due to an increase in the number of COVID-19 cases and the spread of the Omicron variant in Europe. (Bloomberg)
Poland reports its first case of the Omicron variant in a 30-year-old Mosotho woman who is currently in isolation in a hospital in the city of Katowice. (The First News)
Malawi announces that public service workers, healthcare workers and journalists will be required to be vaccinated against COVID-19 beginning on December 20 amid an increase in the number of COVID-19 infections. (Reuters)
The WHO issues interim recommendations for mixing and matching COVID-19 vaccine for second and booster shot, where mRNA-based vaccines can be used as subsequent doses after initial doses of the Oxford-AstraZeneca COVID-19 vaccine and vice versa, while these vaccines can be used after initial doses of Sinopharm's inactived vaccine. (Reuters)